Rocuronium duration of action under sevoflurane, desflurane or propofol anaesthesia

Background and objective: We conducted a prospective randomized study to evaluate whether the duration of action of a single bolus dose of rocuronium is influenced by maintenance of anaesthesia with sevoflurane, desflurane or propofol infusion. Methods: Fifty-seven ASA I-II patients undergoing elective abdominal surgery were enrolled in this study. Anaesthesia was induced with thiopental 3-5 mg kg−1 or propofol 2.5 mg kg−1 and fentanyl 5 μg kg−1 and tracheal intubation was facilitated with rocuronium 0.9 mg kg−1. Thereafter patients were randomly allocated to three different groups to receive sevoflurane, desflurane or propofol for maintenance of anaesthesia. Recovery of neuromuscular function was monitored by single twitch stimulation of the ulnar nerve and by recording the adductor pollicis response using accelerometry. Intergroup recovery times to 5% of control value of single twitch were analysed using analysis of variance with Bonferroni correction. Results: The mean (95% confidence interval) recovery time to 5% of control value of single twitch during desflurane anaesthesia was 90.18 (86.11-94.25) min. Significantly shorter recovery times were observed during sevoflurane or propofol anaesthesia, 58.86 (54.73-62.99) min and 51.11 (45.47-56.74) min, respectively (P < 0.001). There were also significant differences in the recovery time between groups receiving desflurane vs. sevoflurane (P < 0.001) and desflurane vs. propofol (P < 0.001). Conclusions: Desflurane anaesthesia significantly prolongs the duration of action of rocuronium at 0.9 mg kg−1 single bolus dose, compared to sevoflurane or propofol anaesthesia maintenance regimens.

[1]  B. Plaud,et al.  Rocuronium pharmacokinetic-pharmacodynamic relationship under stable propofol or isoflurane anesthesia , 2002, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[2]  M. Giala,et al.  Variations in the duration of action of two aminosteroid neuromuscular blocking agents , 2001 .

[3]  E. Martin,et al.  Rocuronium potency and recovery characteristics during steady-state desflurane, sevoflurane, isoflurane or propofol anaesthesia. , 2000, British journal of anaesthesia.

[4]  Y. Amaki,et al.  Sevoflurane exposure time and the neuromuscular blocking effect of vecuronium , 1999, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[5]  R. Mirakhur,et al.  Neuromuscular Effects of Rocuronium During Sevoflurane, Isoflurane, and Intravenous Anesthesia , 1998, Anesthesia and analgesia.

[6]  T. Ledowski,et al.  Neuromuscular blocking effects of rocuronium during desflurane, isoflurane, and sevoflurane anaesthesia , 1998, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[7]  T. Ledowski,et al.  Augmentation of the neuromuscular blocking effects of cisatracurium during desflurane, sevoflurane, isoflurane or total i.v. anaesthesia. , 1998, British journal of anaesthesia.

[8]  T. Ledowski,et al.  [Augmentation of the neuromuscular blocking effect of mivacurium during inhalation anesthesia with desflurane, sevoflorane and isoflurane in comparison with total intravenous anesthesia]. , 1998, Anaesthesiologie und Reanimation.

[9]  R. Mirakhur,et al.  Potency and time course of action of rocuronium during desflurane and isoflurane anaesthesia. , 1996, British journal of anaesthesia.

[10]  R. Fragen,et al.  The minimum alveolar concentration (MAC) of sevoflurane with and without nitrous oxide in elderly versus young adults. , 1996, Journal of clinical anesthesia.

[11]  T. Taivainen,et al.  Time course of potentiation of mivacurium by halothane and isoflurane in children , 1996 .

[12]  M. Sharma,et al.  The Magnitude and Time Course of Vecuronium Potentiation by Desflurane Versus Isoflurane , 1995, Anesthesiology.

[13]  J. Wierda,et al.  Clinical pharmacology of rocuronium (Org 9426): study of the time course of action, dose requirement, reversibility, and pharmacokinetics. , 1994, Journal of clinical anesthesia.

[14]  C. Meistelman,et al.  Rocuronium (ORG 9426) neuromuscular blockade at the adductor muscles of the larynx and adductor pollicis in humans , 1992, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[15]  C. Meistelman,et al.  Vecuronium neuromuscular blockade at the adductor muscles of the larynx and adductor pollicis. , 1991, Anesthesiology.

[16]  R. Weiskopf,et al.  Clinical characteristics of desflurane in surgical patients: minimum alveolar concentration. , 1991, Anesthesiology.

[17]  E. Eger,et al.  Solubility of I-653, sevoflurane, isoflurane, and halothane in human tissues. , 1989, Anesthesia and analgesia.